An update on ketamine and its two enantiomers as rapid-acting antidepressants
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An update on ketamine and its two enantiomers as rapid-acting antidepressants
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 19, Issue 1, Pages 83-92
Publisher
Informa UK Limited
Online
2018-12-05
DOI
10.1080/14737175.2019.1554434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
- (2018) Michael F. Grunebaum et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite ( S )-Norketamine
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- What Are the Causes for Discrepancies of Antidepressant Actions of (2 R ,6 R )-Hydroxynorketamine?
- (2018) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- Is (S)-norketamine an alternative antidepressant for esketamine?
- (2018) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Rapid antidepressant effect of S-ketamine in schizophrenia
- (2018) Lucie Bartova et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety
- (2018) Shabah Mohammad Shadli et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- OUP accepted manuscript
- (2018) INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders
- (2018) Paul Glue et al. JOURNAL OF PSYCHOPHARMACOLOGY
- (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
- (2018) Jun-ichi Yamaguchi et al. NEUROPSYCHOPHARMACOLOGY
- Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of ( R,S )-ketamine and ( S )-ketamine, but not ( R )-ketamine
- (2018) Zheng Tian et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study
- (2018) Randall L. Morrison et al. PSYCHOPHARMACOLOGY
- Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model
- (2018) Kai Zhang et al. Scientific Reports
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study
- (2018) Mu-Hong Chen et al. PSYCHIATRY RESEARCH
- Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects
- (2018) Ruin Moaddel et al. PSYCHOPHARMACOLOGY
- Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model
- (2018) Kai Zhang et al. PSYCHOPHARMACOLOGY
- Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects?
- (2017) Shigeyuki Chaki INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
- (2017) Yukihiko Shirayama et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The Antidepressant Effect of Repeat Dose Intravenous Ketamine Is Delayed by Concurrent Benzodiazepine Use
- (2017) C. Sophia Albott et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression
- (2017) Minkyung Park et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder
- (2017) B Kadriu et al. MOLECULAR PSYCHIATRY
- The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
- (2017) M Kokkinou et al. MOLECULAR PSYCHIATRY
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial
- (2017) Jerome H Taylor et al. NEUROPSYCHOPHARMACOLOGY
- Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study
- (2017) John Hartberg et al. PSYCHOPHARMACOLOGY
- The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study
- (2017) Aurora J. A. E. van de Loo et al. PSYCHOPHARMACOLOGY
- Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
- (2017) D D Kiraly et al. Translational Psychiatry
- Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
- (2017) Chun Yang et al. Translational Psychiatry
- Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
- (2016) C. K. Loo et al. ACTA PSYCHIATRICA SCANDINAVICA
- Detrimental Side Effects of Repeated Ketamine Infusions in the Brain
- (2016) Kenji Hashimoto AMERICAN JOURNAL OF PSYCHIATRY
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior
- (2016) Rebecca A. Brachman et al. BIOLOGICAL PSYCHIATRY
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
- (2016) Marko A. Peltoniemi et al. CLINICAL PHARMACOKINETICS
- Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression
- (2016) Yukihiko Shirayama et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
- (2016) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Ketamine’s antidepressant action: beyond NMDA receptor inhibition
- (2016) Kenji Hashimoto EXPERT OPINION ON THERAPEUTIC TARGETS
- Ketamine: 50 Years of Modulating the Mind
- (2016) Linda Li et al. Frontiers in Human Neuroscience
- Can Exposure-Based CBT Extend the Effects of Intravenous Ketamine in Obsessive-Compulsive Disorder?
- (2016) Carolyn I. Rodriguez et al. JOURNAL OF CLINICAL PSYCHIATRY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
- (2016) Chun Yang et al. PSYCHIATRY RESEARCH
- Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity
- (2016) K. Hashimoto PSYCHOLOGICAL MEDICINE
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Serum Interleukin-6 Is a Predictive Biomarker for Ketamine’s Antidepressant Effect in Treatment-Resistant Patients With Major Depression
- (2015) Jian-jun Yang et al. BIOLOGICAL PSYCHIATRY
- Concomitant Benzodiazepine Use Attenuates Ketamine Response
- (2015) Mark A. Frye et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression
- (2015) Bruno Romeo et al. PSYCHIATRY RESEARCH
- Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
- (2015) J. W. Murrough et al. PSYCHOLOGICAL MEDICINE
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- The Risk of Switch to Mania in Patients With Bipolar Disorder During Treatment With an Antidepressant Alone and in Combination With a Mood Stabilizer
- (2014) Alexander Viktorin et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
- (2014) Adriana Feder et al. JAMA Psychiatry
- The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
- (2014) Kenji Hashimoto Clinical Psychopharmacology and Neuroscience
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Subanesthetic Dose Ketamine Does Not Induce an Affective Switch in Three Independent Samples of Treatment-Resistant Major Depression
- (2013) Mark J. Niciu et al. BIOLOGICAL PSYCHIATRY
- Neural correlates of rapid antidepressant response to ketamine in bipolar disorder
- (2013) Allison C Nugent et al. BIPOLAR DISORDERS
- Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression
- (2013) Diogo R. Lara et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
- (2013) Scott A. Irwin et al. JOURNAL OF PALLIATIVE MEDICINE
- Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
- (2013) Carolyn I Rodriguez et al. NEUROPSYCHOPHARMACOLOGY
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder
- (2012) Michael H. Bloch et al. BIOLOGICAL PSYCHIATRY
- Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients
- (2012) Gonzalo Laje et al. BIOLOGICAL PSYCHIATRY
- Ketamine for Depression: Where Do We Go from Here?
- (2012) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Acute Increases in Plasma Mammalian Target of Rapamycin, Glycogen Synthase Kinase-3β, and Eukaryotic Elongation Factor 2 Phosphorylation After Ketamine Treatment in Three Depressed Patients
- (2012) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- A BDNF Val66Met Polymorphism and Ketamine-induced Rapid Antidepressant Action
- (2012) Kenji Hashimoto Clinical Psychopharmacology and Neuroscience
- Monitoring Ketamine Treatment Response in a Depressed Patient via Peripheral Mammalian Target of Rapamycin Activation
- (2011) Magdalena C. Denk et al. AMERICAN JOURNAL OF PSYCHIATRY
- A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department
- (2011) Gregory Luke Larkin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Rapid Resolution of Obsessions After an Infusion of Intravenous Ketamine in a Patient With Treatment-Resistant Obsessive-Compulsive Disorder
- (2011) Carolyn I. Rodriguez et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine
- (2010) Kenji Hashimoto Expert Review of Neurotherapeutics
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
- (2009) Rebecca B. Price et al. BIOLOGICAL PSYCHIATRY
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- The Correlation Between Ketamine and Posttraumatic Stress Disorder in Burned Service Members
- (2008) Laura L. McGhee et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started